secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001534969-22-000129
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q3 2022: Revenue $87k, Net Loss $10.7M; Banner Health contract signed
--------------------------------------------------------------------------------

- Q3 revenue $87,000, up from $23,000 YoY; net loss $10.7M vs $9.9M.
- Operating expenses $11.3M, up from $9.5M; R&D $4.2M, SG&A $7.0M.
- Cash, equivalents & securities $111.2M at Sept 30, 2022.
- Banner Health signed for PreTRM test under Medicaid plan (~300k members); revenue possible Q4 2022.
- PRIME study on track; interim look expected 2023; preeclampsia validation data by year-end 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000129/0001534969-22-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496922000129/sera-20221109.htm
  HTML page:      https://secwatch.observer/filing/0001534969-22-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer